In this episode, we delve into the diagnostic utility of metagenomic next-generation sequencing (mNGS) for identifying central nervous system (CNS) infections following craniotomy. Drawing from an abstract of a study published in the Journal of Infection in Developing Countries in 2026, we discuss the challenges associated with traditional methods for diagnosing bacterial meningitis in this vulnerable patient population. The research evaluated mNGS against standard bacterial cultures using cerebrospinal fluid, highlighting its potential to improve diagnostic speed and accuracy. We explore the implications of these findings for clinical decision-making and patient outcomes in neurocritical care settings. This content is for informational purposes only and does not constitute medical advice.